Introduction
============

Multiple squamous cell carcinomas (SCCs) frequently arise in the upper aerodigestive tract [@JR509-1] [@JR509-2]. This phenomenon can be explained by the field cancerization theory, which suggests that the entire epithelial surface of the upper aerodigestive tract is at increased risk of developing cancers because of its repeated exposure to carcinogens such as alcohol and through smoking [@JR509-3] [@JR509-4]. Surveillance of the aerodigestive tract in patients with head and neck (H&N) and esophageal SCCs is therefore recommended based on this theory, and periodic endoscopic examinations in these patients may facilitate the early detection of SCCs in this area [@JR509-5]. Early detection of cancers may be associated with a better prognosis and increased possibility of minimally invasive treatment, including endoscopic resection [@JR509-6] [@JR509-7] [@JR509-8].

Although previous studies have reported on the use of surveillance endoscopic examinations in patients with esophageal cancer [@JR509-9] [@JR509-10] [@JR509-11], they have only included small numbers of patients, and no detailed information on the second primary H&N cancers was provided. However, detailed analyses of second primary H&N cancers may help to elucidate the characteristics of cancers caused by the field cancerization effect, and thus help to establish effective surveillance methods for patients with esophageal cancer. In this study, we therefore investigated the incidence, primary sites, and stages of second primary H&N SCCs detected in patients with esophageal SCC.

Patients and methods
====================

Patients
--------

A total of 818 patients underwent endoscopic resection for superficial esophageal cancer at Osaka Medical Center for Cancer and Cardiovascular Diseases between January 2006 and December 2013. We prospectively collected baseline clinical data for these patients, including treatment date, age, sex, past medical history, and lesion characteristics, such as location, size, histology, and depth of invasion. From this database, we identified 439 patients who met the following inclusion criteria: (1) histologically proven esophageal SCC; (2) mucosal or submucosal esophageal SCC; (3) no prior radiotherapy, chemotherapy, or surgery for esophageal SCC; (4) no prior diagnosis or treatment of H&N SCC; (5) no history of other incurable cancer before endoscopic resection; and (6) followed up with upper gastrointestinal endoscopy in our hospital for more than 6 months ([Fig. 1](#FI509-1){ref-type="fig"})
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In this study, multiple H&N cancers detected after endoscopic resection were classified as metachronous. The incidences and characteristics of metachronous H&N cancers were obtained from electronic medical records. All the lesions were histologically confirmed as SCC according to World Health Organization criteria [@BR509-12]. The lesions were also diagnosed as cancerous based on obvious cytological abnormalities of the squamous epithelium, even when the abnormalities were confined to the lower half of the squamous epithelium [@JR509-13]. This study was approved by the ethics committee at Osaka Medical Center for Cancer and Cardiovascular Diseases.

Follow up
---------

Patients were followed up at our hospital or by the referring physicians after treatment. In this study, we only analyzed second primary H&N cancers in patients who were followed up for more than 6 months in our hospital, to ensure the quality of endoscopic examination.

Surveillance of H&N cancers was conducted by upper gastrointestinal endoscopy and pharyngolaryngoscopy. Upper gastrointestinal endoscopy was generally conducted by gastroenterologists at 2 months after endoscopic resection, and annually thereafter. Most endoscopic examinations were carried out using a magnifying endoscope with narrow-band imaging (NBI) (GIF-Q240Z or GIF-H260Z; Olympus Optical Co Ltd, Tokyo, Japan) fitted with a soft black hood attachment (MB-162 for GIF-Q240Z, or MB-46 for GIF-H260Z; Olympus) on its top. Pharyngolaryngoscopy by otorhinolaryngologist was conducted annually or as dictated by symptoms such as hoarseness or discomfort in swallowing. During endoscopic examination, we observed the oropharynx, hypopharynx, and oral cavity. If a well-demarcated brownish area and microvascular irregularities were observed with NBI, the lesion was diagnosed as endoscopically suspected superficial SCC [@JR509-14], and biopsy samples were taken.

General treatment principles of H&N cancer
------------------------------------------

All detected H&N cancers were treated at our hospital based on a strategy determined by otorhinolaryngologists and gastroenterologists. Lesions that fulfilled the following criteria were treated by minimally invasive treatment, such as transoral surgical mucosectomy or endoscopic resection: (1) cancers limited to the epithelium or invading into the surface part of the subepithelial layer; (2) cancers with no spread into the pharyngeal space bilaterally; and (3) no lymph node or distant metastasis visible by computed tomography. Because lesions in the oral cavity and superior wall of the oropharynx can be accessed easily by a surgical device, transoral surgical mucosectomy was carried out by otorhinolaryngologists. However, if a transoral direct approach was difficult, endoscopic resection was performed by gastrointestinal endoscopists. If the detected lesion did not meet the indication criteria for minimally invasive treatment as mentioned above, radical surgery, radiotherapy, or chemoradiotherapy was considered.

Statistical analysis
--------------------

The cumulative incidence rates of metachronous H&N cancers were plotted using the Kaplan-Meier method. The observation period was measured from the date of endoscopic resection to the date of detection of metachronous multiple cancers, or the latest endoscopic examination in patients in whom multiple cancers were not found. Categorical variables were compared using Yates χ^2^ tests. For all analyses, a two-sided *P* value \< 0.05 was considered statistically significant. Statistical analyses were performed using JMP version 10.0 (SAS Institute, Cary, NC, USA).

Results
=======

The characteristics of the 439 patients and the esophageal lesions are listed in [Table 1](#TB509-1){ref-type="table"}. For patients with synchronous multiple esophageal SCCs, data for the deepest or largest lesion are shown. The patients included 370 men and 69 women, with a median age of 68 years (range 41 -- 83). Eighteen patients had submucosal cancer with lymphovascular involvement, 42 had submucosal cancer without lymphovascular involvement, and 23 had mucosal cancer with lymphovascular involvement. Of these 83 patients, additional treatment was performed in 71 patients (63 chemoradiotherapy, 7 surgery, and 1 chemotherapy) to reduce the risk of lymph node metastasis. The remaining 12 patients did not receive the additional treatment because of patient refusal in 11 cases and liver cirrhosis in 1 case.

###### Characteristics of patients and lesions.

  --------------------------------- ----------------
  Gender, male/female, n            370/69
  Age, median (range), y             68 (41 -- 83)
  Lesion location, n                
   Cervical esophagus                51
   Upper thoracic esophagus         115
   Middle thoracic esophagus        197
   Lower thoracic esophagus          76
  Lesion size, median (range), mm    12 (2 -- 80)
  Tumor depth, n                    
   EP                               118
   LPM                              171
   MM                                90
   SM                                60
  Lymphovascular involvement, n     
   Positive                          41
   Negative                         398
  --------------------------------- ----------------

EP, epithelium; LPM, lamina propria; MM, muscularis mucosa; SM, submucosa.

Among all the patients, 98 % (428/439) received follow-up examinations at 1 year, 79 % (346/439) at 2 years, 60 % (264/439) at 3 years, 44 % (191/439) at 4 years, and 28 % (123/439) at 5 years. A total of 53 metachronous H&N cancers developed in 40 patients after median follow-up of 46 months (range 9 -- 109), with cumulative incidence rates of metachronous H&N cancers at 3, 5, and 7 years of 5.3 %, 9.7 %, and 17.2 %, respectively ([Fig. 2](#FI509-2){ref-type="fig"}). The characteristics of the metachronous H&N cancers are listed in [Table 2](#TB509-2){ref-type="table"}. Thirty-five lesions were located in the hypopharynx, 9 in the oropharynx, 4 in the oral cavity, and 5 in the larynx. Four lesions were detected by otorhinolaryngologists (1 lateral wall of oropharynx, 2 oral floor, and 1 glottis), and all of the remaining lesions were detected by gastroenterologists. Among all the subsites in the H&N region, 70 % of lesions were located at the pyriform sinus (47 %, 25/53) or posterior wall of the pharynx (23 %, 12 /53). The median size of the detected lesions was 17 mm (range 2 -- 45 mm). Minimally invasive treatment such as endoscopic resection or transoral surgical mucosectomy was conducted for 39 of the 53 lesions (74 %).  [Table 3](#TB509-3){ref-type="table"} shows the T and N stages of the detected cancers (no distant metastasis was detected in any of the lesions). Most of the lesions (70 %, 37/53) were classified as Tis/T1N0, although 4 lesions had lymph node metastasis when their primary sites were detected (1 postcricoid area, 2 posterior wall of hypopharynx, and 1 lateral wall of oropharynx). Three of 5 protruded lesions and 1 of 46 flat lesions had lymph node metastasis. There was a significant association (*P* = 0.0002) between endoscopic appearance (protruded or flat) and N stage (N0 or N1 -- 2).
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###### Characteristics of metachronous head and neck cancers.

  ------------------------------------------------------------- --------------
  Patients, n (%)                                               40 (9.1)
  Lesions, n                                                    53
  Lesion location, n                                            
   Hypopharynx                                                  
    Left pyriform sinus                                         10
    Right pyriform sinus                                        15
    Postcricoid area                                             3
    Posterior wall                                               7
   Oropharynx                                                   
    Superior wall                                                3
    Posterior wall                                               5
    Lateral wall                                                 1
   Oral cavity                                                  
    Oral floor                                                   2
    Buccal mucosa                                                2
   Larynx                                                       
    Supraglottis                                                 4
    Glottis                                                      1
  Lesion size, median (range), mm                               17 (2 -- 45)
  Macroscopic appearance, n[1](#FN509-1){ref-type="table-fn"}   
   Flat                                                         46
   Protruded                                                     5
  Treatment, n                                                  
   Endoscopic resection                                         31
   Transoral surgical mucosectomy                                8
   Radical surgery                                               3
   Radiotherapy                                                  4
   Chemoradiotherapy                                             3
   Endoscopic resection & radiotherapy                           1
   Surgery & radiotherapy                                        1
   Surgery & chemoradiotherapy                                   1
   Observation[2](#FN509-2){ref-type="table-fn"}                 1
  ------------------------------------------------------------- --------------

Macroscopic types of 2 lesions were not recorded

Lesions were not recorded ^2^because of other incurable cancer

###### T and N stages of metachronous head and neck cancers.

                      TN stage, n           
  ------------------- ------------- --- --- ---
  Hypopharynx                               
   Pyriform sinus     17            7   1   0
   Postcricoid area    2            0   0   1
   Posterior wall      5            0   0   2
  Oropharynx                                
   Superior wall       2            1   0   0
   Posterior wall      4            1   0   0
   Lateral wall        0            0   0   1
  Oral cavity          2            2   0   0
  Larynx               5            0   0   0

Discussion
==========

In this study, we demonstrated a cumulative 5-year incidence rate of 9.7 % for metachronous H&N SCC in patients with esophageal SCC. The pyriform sinus and posterior wall of the pharynx were the most common sites for the development of metachronous SCCs. Most of the lesions were detected at an early stage and were completely removed by minimally invasive treatment, such as transoral surgical mucosectomy or endoscopic resection. However, some lesions in the postcricoid area and posterior wall of the hypopharynx were initially diagnosed at an advanced stage.

In Japan, the age-specific annual incidence rate for oral and pharyngeal cancer in 65- to 69-year-olds was 30.6 per 100,000 in 2008 [@JR509-15]. Compared with the general population, our study demonstrated that patients with esophageal cancer were at extremely high risk of developing H&N cancers, with an incidence of approximately 2000 per 100,000 patients. We also previously reported that metachronous esophageal cancer frequently developed in patients who had undergone endoscopic resection for esophageal cancer (cumulative incidence rate at 5 years of 20.6 %) [@JR509-16]. These studies demonstrate that the entire epithelial surface of the upper digestive tract is at increased risk of cancer in patients with esophageal cancer, thus supporting the field cancerization theory.

According to the H&N cancer registry in Japan, a total of 3899 H&N cancers were newly diagnosed in 2012, 840 of which (22 %) were classified as Tis/T1N0, and 249 (6.4 %) of which were treated by minimally invasive methods, such as transoral surgical mucosectomy or endoscopic resection [@JR509-17]. In this study using periodic endoscopic surveillance with NBI, 70 % (37/53) of lesions were detected as Tis/T1N0 cancers, and 39 of the 53 lesions (74 %) were treated by minimally invasive procedures. These results indicate that periodic endoscopic surveillance facilitates the early detection of H&N cancers, and suggest that NBI may also be relevant [@JR509-18].

Effective surveillance requires an understanding of the detailed features, such as the annual incidence and common sites of H&N cancers. Katada et al. reported the prevalence of superficial H&N cancers in patients with esophageal cancer, but not their annual incidence [@JR509-10]. Hori et al. investigated the annual incidence of H&N cancers, but the number of lesions was relatively small and their detailed locations were not reported [@JR509-9]. The H&N cancer registry in Japan shows the detailed locations of the cancers, but most cancers included in the registry are advanced cases [@JR509-17]. The current study is thus the largest to demonstrate the incidence of superficial H&N cancers in patients with esophageal cancer, with detailed information on the locations and stages of the lesions. Although this study was conducted in patients with esophageal cancer, the findings regarding cancer location might be applied to cancers arising based on the field cancerization theory.

In this study, H&N cancers were frequently located at the pyriform sinus or posterior wall of the pharynx (70 %, 37/53 lesions). Because the structure of the H&N region is complex and it is difficult to view the region thoroughly, information on the most common sites of H&N cancers may help effective surveillance. Although we detected most H&N lesions at an early phase, some lesions in the postcricoid area and posterior wall of the hypopharynx already had lymph node metastasis when their primary sites were discovered. These anatomically adjacent sites in the hypopharynx constitute a closed space, which disturbs us to notice subtile changes in the muscosa during endoscopic observation ([Fig. 3](#FI509-3){ref-type="fig"}). Methods to open this closed space, such as the Valsalva maneuver, would facilitate detection of these lesions, and such methods should thus be included as a part of the routine surveillance program.
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Our study was limited by its retrospective, single-center design, and by the large number of patients (115 patients) who were lost to follow up. However, conducting a multicenter study would be difficult given that there is currently no established surveillance program for H&N cancer. Furthermore, limiting the patients who were followed up at our hospital allowed us to maintain similar surveillance intervals and similar qualities of endoscopic examinations for H&N cancer. Despite the limitations, the results of this study will thus contribute to the development of future surveillance programs.

In conclusion, the 5-year incidence of metachronous H&N SCC in patients with esophageal SCC was 9.7 %, with the pyriform sinus and posterior wall of the pharynx being the most common sites. A standardized surveillance program for H&N SCC should be developed for patients with esophageal SCC.
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